Morpholino

MO2-scap

ID

ZDB-MRPHLNO-110425-1

Name

MO2-scap

Previous Names

Target

Sequence

5' - CCCGATACTGCAAGAAGATT - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Splice-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-scap

No data available

Phenotype

Phenotype resulting from MO2-scap

Phenotype	Fish	Figures
liver cell fatty, abnormal	WT + MO2-scap	Fig. 4 from Zhang et al., 2016

Phenotype of all Fish created by or utilizing MO2-scap

Phenotype	Fish	Conditions	Figures
liver cell fatty, abnormal	WT + MO2-scap	chemical treatment by environment: ethanol	Fig. 4 from Zhang et al., 2016
liver cell fatty, ameliorated	WT + MO2-scap	chemical treatment by environment: N-(4-chloro-2-fluorophenyl)-6,7-dimethoxy-4-quinazolinamine	Fig. 4 from Zhang et al., 2016
liver fatty, abnormal	WT + MO2-scap	fasting	Fig. 4 from Cinaroglu et al., 2011
liver cell fatty, ameliorated	WT + MO2-scap	chemical treatment by environment: ethanol, chemical treatment by environment: N-(4-chloro-2-fluorophenyl)-6,7-dimethoxy-4-quinazolinamine	Fig. 4 from Zhang et al., 2016
liver cell fatty, abnormal	WT + MO2-scap	control	Fig. 4 from Zhang et al., 2016
hepatocyte decreased functionality, abnormal	lri500Tg; s896Tg + MO2-scap	chemical treatment: ethanol	Fig. 5 from Howarth et al., 2013
liver fatty, abnormal	trappc11^hi1532bTg + MO2-scap	standard conditions	Fig. 4 from Cinaroglu et al., 2011

Citations